期刊
JOURNAL OF CELL BIOLOGY
卷 199, 期 3, 页码 407-412出版社
ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.201208082
关键词
-
类别
资金
- Danish National Advanced Technology Foundation [006-2005-1, 044-2007-1]
MicroRNAs (miRNAs) are important post-transcriptional regulators of nearly every biological process in the cell and play key roles in the pathogenesis of human disease. As a result, there are many drug discovery programs that focus on developing miRNA-based therapeutics. The most advanced of these programs targets the liver-expressed miRNA-122 using the locked nucleic acid (LNA)-modified antisense oligonucleotide miravirsen. Here, we describe the discovery of miravirsen, which is currently in phase 2 clinical trials for treatment of hepatitis C virus (HCV) infection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据